CODX
Income statement / Annual
Last year (2024), Co-Diagnostics, Inc.'s total revenue was $3.92 M,
a decrease of 42.53% from the previous year.
In 2024, Co-Diagnostics, Inc.'s net income was -$37.64 M.
See Co-Diagnostics, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$3.92 M |
$6.81 M |
$34.22 M |
$97.89 M |
$74.55 M |
$214.97 K |
$39.91 K |
$7.66 K |
$0.00 |
$10.00 K |
| Cost of Revenue |
$999.12 K
|
$4.18 M
|
$5.48 M
|
$11.57 M
|
$16.59 M
|
$112.43 K
|
$9.39 K
|
$302.00
|
$37.49 K
|
$43.14 K
|
| Gross Profit |
$2.92 M
|
$2.63 M
|
$28.74 M
|
$86.31 M
|
$57.96 M
|
$102.54 K
|
$30.52 K
|
$7.36 K
|
-$37.49 K
|
-$33.14 K
|
| Gross Profit Ratio |
0.74
|
0.39
|
0.84
|
0.88
|
0.78
|
0.48
|
0.76
|
0.96
|
0
|
-3.31
|
| Research and Development Expenses |
$20.98 M
|
$22.96 M
|
$17.44 M
|
$14.96 M
|
$3.19 M
|
$1.37 M
|
$1.36 M
|
$1.00 M
|
$731.47 K
|
$806.91 K
|
| General & Administrative Expenses |
$16.16 M
|
$14.28 M
|
$14.26 M
|
$11.55 M
|
$8.28 M
|
$3.50 M
|
$3.57 M
|
$3.10 M
|
$796.90 K
|
$846.83 K
|
| Selling & Marketing Expenses |
$4.48 M
|
$6.86 M
|
$7.34 M
|
$13.40 M
|
$4.67 M
|
$1.06 M
|
$1.17 M
|
$426.71 K
|
$122.11 K
|
$281.10 K
|
| Selling, General & Administrative Expenses |
$20.64 M
|
$21.14 M
|
$21.61 M
|
$24.95 M
|
$12.94 M
|
$4.56 M
|
$4.74 M
|
$3.52 M
|
$919.00 K
|
$1.13 M
|
| Other Expenses |
$1.38 M
|
$1.23 M
|
$1.28 M
|
$335.36 K
|
$138.64 K
|
$65.90 K
|
$50.77 K
|
$45.76 K
|
$0.00
|
$43.14 K
|
| Operating Expenses |
$43.00 M
|
$45.33 M
|
$40.33 M
|
$40.25 M
|
$16.27 M
|
$6.00 M
|
$6.15 M
|
$4.57 M
|
$1.69 M
|
$1.98 M
|
| Cost And Expenses |
$43.00 M
|
$49.52 M
|
$45.81 M
|
$51.82 M
|
$32.86 M
|
$6.11 M
|
$6.16 M
|
$4.57 M
|
$1.69 M
|
$1.98 M
|
| Interest Income |
$1.09 M
|
$1.16 M
|
$704.05 K
|
$45.63 K
|
$97.22 K
|
$36.65 K
|
$19.80 K
|
$3.83 K
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$106.44 K
|
$134.95 K
|
$310.23 K
|
$240.72 K
|
$75.19 K
|
| Depreciation & Amortization |
$1.38 M
|
$1.23 M
|
$1.31 M
|
$335.36 K
|
$138.64 K
|
$65.90 K
|
$50.77 K
|
$46.06 K
|
$37.49 K
|
$43.14 K
|
| EBITDA |
-$38.70 M |
-$41.48 M |
-$10.31 M |
$46.40 M |
$41.83 M |
-$6.02 M |
-$6.09 M |
-$6.60 M |
-$1.65 M |
-$1.92 M |
| EBITDA Ratio |
-9.89
|
-6.09
|
-0.3
|
0.47
|
0.56
|
-28.02
|
-152.49
|
-861.78
|
0
|
-192.48
|
| Operating Income Ratio |
-10.24
|
-6.27
|
-0.34
|
0.47
|
0.56
|
-27.42
|
-153.29
|
-595.68
|
0
|
-196.8
|
| Total Other Income/Expenses Net |
$2.50 M
|
$4.60 M
|
$8.13 M
|
-$429.16 K
|
$875.43 K
|
-$301.82 K
|
-$153.91 K
|
-$2.40 M
|
-$240.72 K
|
-$75.19 K
|
| Income Before Tax |
-$37.58 M
|
-$38.11 M
|
-$18.85 M
|
$45.64 M
|
$42.57 M
|
-$6.20 M
|
-$6.27 M
|
-$6.96 M
|
-$1.93 M
|
-$2.04 M
|
| Income Before Tax Ratio |
-9.6
|
-5.59
|
-0.55
|
0.47
|
0.57
|
-28.82
|
-157.14
|
-908.28
|
0
|
-204.32
|
| Income Tax Expense |
$57.37 K
|
-$2.78 M
|
-$4.61 M
|
$8.98 M
|
$90.54 K
|
-$126.44 K
|
-$18.96 K
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$37.64 M
|
-$35.33 M
|
-$14.24 M
|
$36.66 M
|
$42.48 M
|
-$6.07 M
|
-$6.27 M
|
-$6.96 M
|
-$1.93 M
|
-$2.04 M
|
| Net Income Ratio |
-9.61
|
-5.19
|
-0.42
|
0.37
|
0.57
|
-28.23
|
-157.14
|
-908.28
|
0
|
-204.32
|
| EPS |
-1.24 |
-1.2 |
-0.45 |
1.27 |
1.59 |
-0.36 |
-0.5 |
-0.63 |
-0.17 |
-0.18 |
| EPS Diluted |
-1.24 |
-1.2 |
-0.45 |
1.23 |
1.52 |
-0.36 |
-0.5 |
-0.63 |
-0.17 |
-0.18 |
| Weighted Average Shares Out |
$30.34 M
|
$29.35 M
|
$31.48 M
|
$28.87 M
|
$26.72 M
|
$16.76 M
|
$12.48 M
|
$10.96 M
|
$11.06 M
|
$11.06 M
|
| Weighted Average Shares Out Diluted |
$30.34 M
|
$29.35 M
|
$31.48 M
|
$29.90 M
|
$28.00 M
|
$16.76 M
|
$12.48 M
|
$10.96 M
|
$11.18 M
|
$11.18 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
